News & Updates

Show Multimedia Only

Prior herpes zoster vaccination mitigates long-term complications after infection

20 Nov 2025 by

For individuals who sustained herpes zoster infection, prior receipt of recombinant zoster vaccine appears to reduce the long-term risks of major adverse cardiovascular events, dementia, and death, according to a retrospective study.

Prior herpes zoster vaccination mitigates long-term complications after infection

20 Nov 2025

Radiotherapy vs imiquimod: Which is a better nonsurgical option for lentigo maligna?

20 Nov 2025

Radiotherapy and imiquimod are both efficacious and well-tolerated in patients with complex lentigo maligna who are not suitable for surgery, with no negative effects on health-related quality of life (HRQoL) at 24 months, reports a study.

Radiotherapy vs imiquimod: Which is a better nonsurgical option for lentigo maligna?

20 Nov 2025

Novel technology delivers remote detection of skin diseases

20 Nov 2025 by

A recent study has shown the potential of the three-dimensional total body photography (3D TBP) in diagnosing general skin diseases, with high acceptance from both physicians and patients.

Novel technology delivers remote detection of skin diseases

20 Nov 2025

JAK inhibitor exposure affects response to ritlecitinib for alopecia areata

19 Nov 2025

In patients with alopecia areata who received treatment with ritlecitinib, prior exposure to Janus kinase inhibitors is associated with reduced early response, reveals a study.

JAK inhibitor exposure affects response to ritlecitinib for alopecia areata

19 Nov 2025

Infection risk higher in adalimumab users with HS vs psoriasis

16 Nov 2025

Among adults receiving adalimumab treatment, those with hidradenitis suppurativa appear to be at greater risk of infection than their psoriasis counterparts, as reported in a retrospective study.

Infection risk higher in adalimumab users with HS vs psoriasis

16 Nov 2025

ACNE SCAR SUMMIT 2025: ERASE THE TRACE Innovations and Multimodal Strategies in Acne Scar Management

14 Nov 2025

ACNE SCAR SUMMIT 2025: ERASE THE TRACE Innovations and Multimodal Strategies in Acne Scar Management

14 Nov 2025

Denifanstat reduces lesions in acne vulgaris

01 Nov 2025 by

The fatty acid synthase inhibitor denifanstat shows potential for treating moderate-to-severe acne vulgaris, with good safety and tolerability, as demonstrated in a study from China presented at EADV 2025.

Denifanstat reduces lesions in acne vulgaris

01 Nov 2025

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

New drug applications approved by US FDA as of 16-30 September 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

Nivolumab bests ipilimumab in head-to-head melanoma trial

28 Oct 2025 by

The final, long-term results from the phase III CheckMate 238 trial continue to show the superior recurrence-free survival (RFS) benefit of adjuvant nivolumab (NIVO) over ipilimumab (IPI) for resected stage IIIB-C or IV melanoma.

Nivolumab bests ipilimumab in head-to-head melanoma trial

28 Oct 2025

Pooled data support ruxolitinib cream for treating prurigo nodularis

23 Oct 2025 by

Twice-daily application of ruxolitinib cream led to early and sustained improvement in the signs and symptoms of prurigo nodularis in adults, according to the pooled phase III TRuE-PN1 and TRuE-PN2 studies presented at EADV 2025.

Pooled data support ruxolitinib cream for treating prurigo nodularis

23 Oct 2025

News & Updates

Showing Dermatology articles

Showing

Specialty:

Prior herpes zoster vaccination mitigates long-term complications after infection

Prior herpes zoster vaccination mitigates long-term complications after infection

Radiotherapy vs imiquimod: Which is a better nonsurgical option for lentigo maligna?

Radiotherapy vs imiquimod: Which is a better nonsurgical option for lentigo maligna?

Novel technology delivers remote detection of skin diseases

Novel technology delivers remote detection of skin diseases

JAK inhibitor exposure affects response to ritlecitinib for alopecia areata

JAK inhibitor exposure affects response to ritlecitinib for alopecia areata

Infection risk higher in adalimumab users with HS vs psoriasis

Infection risk higher in adalimumab users with HS vs psoriasis

ACNE SCAR SUMMIT 2025: ERASE THE TRACE Innovations and Multimodal Strategies in Acne Scar Management

ACNE SCAR SUMMIT 2025: ERASE THE TRACE Innovations and Multimodal Strategies in Acne Scar Management

Denifanstat reduces lesions in acne vulgaris

Denifanstat reduces lesions in acne vulgaris

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Nivolumab bests ipilimumab in head-to-head melanoma trial

Nivolumab bests ipilimumab in head-to-head melanoma trial

Pooled data support ruxolitinib cream for treating prurigo nodularis

Pooled data support ruxolitinib cream for treating prurigo nodularis